YEXT — what changed in the latest 10-Q
A section-by-section comparison of YEXT's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-09-01 vs the prior 10-Q · 2026-06-02
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +16 | −7 | ~19 | 51 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~1 | 12 |
| Controls & procedures | Text added/removed | 0 | 0 | ~1 | 12 |
| Legal proceedings | Text added/removed | 0 | 0 | ~1 | 12 |
| Risk factors | Text added/removed | +3 | −1 | ~9 | 311 |
| Other information | Text added/removed | 0 | 0 | ~1 | 12 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-09-01
Cost of revenue was $27.3 million for the three months ended July 31, 2026, compared to $28.1 million for the three months ended July 31, 2025, a decrease of $0.8 million or 3%. The decrease was primarily driven by a $0.7 million decrease in personnel-related costs, reflecting lower headcount, and a…
Sales and marketing expense was $26.3 million for the three months ended July 31, 2026, compared to $32.1 million for the three months ended July 31, 2025, a decrease of $5.8 million or 18%. The decrease was primarily driven by a $4.4 million decrease in personnel-related costs, reflecting lower hea…
Research and development expense was $19.4 million for the three months ended July 31, 2026, compared to $23.4 million for the three months ended July 31, 2025, a decrease of $4.0 million or 17%. The decrease was primarily driven by employee-related costs as personnel-related costs decreased $1.6 mi…
General and administrative expense was $20.6 million for the three months ended July 31, 2026, compared to a $0.1 million benefit for the three months ended July 31, 2025, an increase of $20.7 million. The increase was primarily driven by changes in the fair value of contingent consideration of $23.…
Six Months Ended July 31, 2026 Compared to Six Months Ended July 31, 2025
Text removed vs the prior filing · source: 10-Q · 2026-06-02
Cost of revenue was $29.2 million for the three months ended April 30, 2026, compared to $27.1 million for the three months ended April 30, 2025, an increase of $2.1 million or 8%. The increase was primarily driven by a $1.1 million increase in data center costs. In addition, asset impairment charge…
Sales and marketing expense was $29.4 million for the three months ended April 30, 2026, compared to $36.2 million for the three months ended April 30, 2025, a decrease of $6.8 million or 19%. The decrease was primarily driven by employee-related costs as personnel-related costs decreased $5.7 milli…
Research and development expense was $21.5 million for the three months ended April 30, 2026, compared to $21.9 million for the three months ended April 30, 2025, a decrease of $0.4 million or 2%. The decrease was primarily driven by a $0.8 million decrease in personnel-related costs, reflecting low…
General and administrative expense was $22.3 million for the three months ended April 30, 2026, compared to $23.2 million for the three months ended April 30, 2025, a decrease of $0.9 million or 4%. The decrease was primarily driven by changes in the fair value of contingent consideration of $1.6 mi…
Beginning with the three months ended April 30, 2026, we revised our definition of Non-GAAP net income (loss) and Adjusted EBITDA to include asset impairment charges associated with capitalized implementation costs of cloud computing arrangements. We believe this change provides investors with a vie…
Risk factors
Text added vs the prior filing · source: 10-Q · 2026-09-01
In addition, artificial intelligence (“AI”) is forcing rapid evolution of multiple industries. The introduction of alternative tools to traditional software is changing market opportunities and customer behavior generally. While we seek to anticipate our customers’ needs, any such changes in the gen…
adequately expand and scale our sales force, we will experience further delays in signing new customers, which could slow our revenue growth.
For the fiscal years ended January 31, 2026, 2025 and 2024, the aggregate of our top five customers accounted for approximately 8%, 8% and 9%, respectively, of our revenue. During the three months ended January 31, 2024, we experienced the attrition of one of these top five customers, and the corres…
Text removed vs the prior filing · source: 10-Q · 2026-06-02
For the fiscal years ended January 31, 2026, 2025 and 2024, the aggregate of our top five customers accounted for approximately 8%, 8% and 9%, respectively, of our revenue. During the three months ended January 31, 2024, we experienced the attrition of one of these top five customers, and the corres…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice